Skip to main content
Clinical Trials/ITMCTR2000003608
ITMCTR2000003608
Not yet recruiting
Phase 1

A multi-center clinical study on the treatment of knee osteoarthritis with Qubi Yangge Decoction combined with three steps and nine methods of whole knee

onghua Hospital, Shanghai University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
onghua Hospital, Shanghai University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
onghua Hospital, Shanghai University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who meet the diagnostic criteria of knee osteoarthritis and TCM syndrome differentiation standards;
  • 2\. Patients who voluntarily receive drug treatment;
  • 3\. Patients who have not taken other drugs for knee osteoarthritis 2 weeks before treatment;
  • 4\. Informed consent form has been signed and guaranteed Patients who have completed the course of treatment.

Exclusion Criteria

  • 1\. Those who do not meet the diagnostic criteria of Western medicine for knee osteoarthritis and the criteria of TCM syndrome differentiation;
  • 2\. Those under the age of 40;
  • 3\. Women who are breastfeeding or preparing to become pregnant;
  • 4\. Those with allergies and allergies to multiple drugs;
  • 5\. With liver, kidney, Patients with primary diseases such as hematopoietic system and endocrine system and mental illness;
  • 6\. those who are critically ill and should be treated with surgery;
  • 7\. mentally or legally disabled;
  • 8\. suspected to have a history of alcohol or drug abuse, or according to judgment, have reduced income Group possibility or other medical history that complicates the enrollment, such as frequent changes in the work environment, which may easily lead to loss of follow\-up;
  • 9\. Subjects who are participating in clinical studies of other drugs;
  • 10\. In critical condition, it is difficult to determine the effectiveness and safety of the drug The person who makes an accurate assessment of sex.

Outcomes

Primary Outcomes

Not specified

Similar Trials